0001114220-17-000040.txt : 20171031 0001114220-17-000040.hdr.sgml : 20171031 20171031161141 ACCESSION NUMBER: 0001114220-17-000040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171030 FILED AS OF DATE: 20171031 DATE AS OF CHANGE: 20171031 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Madison Greg CENTRAL INDEX KEY: 0001564955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 171165841 MAIL ADDRESS: STREET 1: ONE MARINA PARK DRIVE CITY: LEXINGTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-466-3500 MAIL ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 4 1 wf-form4_150948068741523.xml FORM 4 X0306 4 2017-10-30 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001564955 Madison Greg C/O KERYX BIOPHARMACEUTICALS, INC. ONE MARINA PARK DRIVE, 12TH FLOOR BOSTON MA 02210 1 1 0 0 President and CEO Common Stock 2017-10-30 4 S 0 4055 6.03 D 368687 D Sale of a total of 4,055 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 12,813 shares of restricted stock on October 27, 2017. Mr. Madison had no discretion with respect to such sale, which was transacted in accordance with the Issuer's corporate policies regarding the vesting of restricted stock. Includes 216,882 shares of restricted stock. /s/ Brian Adams, Attorney-in-Fact 2017-10-31